MyAverix Finance
US · Healthcare
ARS Pharmaceuticals, Inc (SPRY)
Biotechnology
ARS Pharmaceuticals, Inc (SPRY) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for SPRY
ARS Pharmaceuticals, Inc (SPRY) — FAQ
What is SPRY's P/E ratio?
The price-to-earnings (P/E) ratio for ARS Pharmaceuticals, Inc (SPRY) is 18.00 (data as of 2026-03-24).
Does ARS Pharmaceuticals, Inc pay a dividend?
Dividend yield is not available in the current snapshot for ARS Pharmaceuticals, Inc (SPRY). Check the MyAverix Finance app for the latest dividend data.
What sector is ARS Pharmaceuticals, Inc in?
ARS Pharmaceuticals, Inc (SPRY) is classified in the Healthcare sector (Biotechnology industry).
What exchange is SPRY listed on?
SPRY is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.